MX2009007765A - Derivados de azabiciclo-octano, el metodo de obtenerlos y sus usos como inhibidores de la dipeptidil-peptidasa iv. - Google Patents

Derivados de azabiciclo-octano, el metodo de obtenerlos y sus usos como inhibidores de la dipeptidil-peptidasa iv.

Info

Publication number
MX2009007765A
MX2009007765A MX2009007765A MX2009007765A MX2009007765A MX 2009007765 A MX2009007765 A MX 2009007765A MX 2009007765 A MX2009007765 A MX 2009007765A MX 2009007765 A MX2009007765 A MX 2009007765A MX 2009007765 A MX2009007765 A MX 2009007765A
Authority
MX
Mexico
Prior art keywords
inhibitors
derivatives
making
dipeptidyl peptidase
azabicyclo octane
Prior art date
Application number
MX2009007765A
Other languages
English (en)
Spanish (es)
Inventor
Li Li
Zhigang Lin
Fuqiang Zhao
Pengcho Tang
Hejun Lue
Original Assignee
Shanghai Hengrui Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Hengrui Pharm Co Ltd filed Critical Shanghai Hengrui Pharm Co Ltd
Publication of MX2009007765A publication Critical patent/MX2009007765A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
MX2009007765A 2007-01-23 2007-10-30 Derivados de azabiciclo-octano, el metodo de obtenerlos y sus usos como inhibidores de la dipeptidil-peptidasa iv. MX2009007765A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNA2007100043308A CN101230058A (zh) 2007-01-23 2007-01-23 双环氮杂烷类衍生物、其制备方法及其在医药上的用途
PCT/CN2007/070990 WO2008089636A1 (en) 2007-01-23 2007-10-30 Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase iv

Publications (1)

Publication Number Publication Date
MX2009007765A true MX2009007765A (es) 2009-07-30

Family

ID=39644101

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009007765A MX2009007765A (es) 2007-01-23 2007-10-30 Derivados de azabiciclo-octano, el metodo de obtenerlos y sus usos como inhibidores de la dipeptidil-peptidasa iv.

Country Status (11)

Country Link
US (1) US8178575B2 (https=)
EP (1) EP2133077B1 (https=)
JP (1) JP5424256B2 (https=)
KR (1) KR101482159B1 (https=)
CN (2) CN101230058A (https=)
AU (1) AU2007345133B8 (https=)
BR (1) BRPI0719650A2 (https=)
CA (1) CA2673164C (https=)
MX (1) MX2009007765A (https=)
RU (1) RU2447063C2 (https=)
WO (1) WO2008089636A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101469306B1 (ko) * 2008-01-23 2014-12-04 장쑤 한서 파마슈티칼 캄파니 리미티드 다이사이클로아자알칸 유도체, 이의 제조 방법 및 의학적 용도
CN101919851B (zh) * 2009-06-09 2012-02-08 江苏恒瑞医药股份有限公司 治疗哺乳动物包括人2型糖尿病的药物组合物
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2011157827A1 (de) 2010-06-18 2011-12-22 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
KR102032934B1 (ko) * 2011-12-21 2019-10-16 지앙수 헨그루이 메디슨 컴퍼니 리미티드 피롤 6원 헤테로아릴 고리 유도체, 그의 제조 방법, 및 그의 의약 용도
CN102827064B (zh) * 2012-08-14 2014-01-29 华东师范大学 一种氮杂双环[3.3.0]辛烷衍生物的合成方法
CN102827063B (zh) * 2012-08-14 2014-06-25 华东师范大学 一种氮杂双环[3.3.0]辛烷衍生物的合成方法
CN103709150B (zh) * 2012-10-09 2017-06-30 江苏豪森药业集团有限公司 托西酸贝格列汀晶型及其制备方法和用途
WO2014064215A1 (en) 2012-10-24 2014-05-01 INSERM (Institut National de la Santé et de la Recherche Médicale) TPL2 KINASE INHIBITORS FOR PREVENTING OR TREATING DIABETES AND FOR PROMOTING β-CELL SURVIVAL
WO2015048507A1 (en) * 2013-09-26 2015-04-02 Mnemosyne Pharmaceuticals, Inc. Selective octahydro-cyclopenta[c] pyrrole negative modulators of nr2b
US10426818B2 (en) 2015-03-24 2019-10-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Method and pharmaceutical composition for use in the treatment of diabetes
MX391179B (es) 2016-11-23 2025-03-21 Jiangsu Hengrui Medicine Co Método de preparación e intermediario de derivado de un anillo heteroaromático de seis miembros pirrolo
US12600726B2 (en) 2017-07-12 2026-04-14 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor M4
IL310346A (en) 2017-10-20 2024-03-01 Univ Vanderbilt Muscarinic acetylcholine M4 receptor antagonists
AU2018360581A1 (en) 2017-10-31 2020-06-11 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor M4
JP2021506972A (ja) 2017-12-15 2021-02-22 プラクシス バイオテック エルエルシー 線維芽細胞活性化タンパク質の阻害剤
CN111788182B (zh) 2018-02-02 2023-09-26 范德堡大学 毒蕈碱性乙酰胆碱受体m4的拮抗剂
CN113811529A (zh) 2018-12-21 2021-12-17 普拉西斯生物技术有限责任公司 成纤维细胞激活蛋白抑制剂
CN111620816B (zh) * 2020-05-27 2023-06-02 上海赛默罗生物科技有限公司 螺桨烷类衍生物、其制备方法、药物组合物和用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280028A (en) * 1992-06-24 1994-01-18 G. D. Searle & Co. Benzimidazole compounds
DE69511086T2 (de) * 1994-05-18 2000-01-05 Nisshin Flour Milling Co., Ltd. Pyrimidinderivate
TW492957B (en) 1996-11-07 2002-07-01 Novartis Ag N-substituted 2-cyanopyrrolidnes
US6110949A (en) 1999-06-24 2000-08-29 Novartis Ag N-(substituted glycyl)-4-cyanothiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
US6395767B2 (en) * 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
HUP0200849A2 (hu) * 2002-03-06 2004-08-30 Sanofi-Synthelabo N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
TW200401635A (en) * 2002-07-23 2004-02-01 Yamanouchi Pharma Co Ltd 2-Cyano-4-fluoropyrrolidine derivative or salt thereof
WO2004080966A1 (ja) * 2003-03-14 2004-09-23 Ono Pharmaceutical Co., Ltd. 含窒素複素環誘導体およびそれらを有効成分とする薬剤
WO2004087142A1 (en) * 2003-04-04 2004-10-14 Novartis Ag Quinoline-2-one-derivatives for the treatment of airways diseases
GB0307856D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Organic compounds
US7288563B2 (en) * 2004-02-19 2007-10-30 Bristol-Myers Squibb Company Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
US7381738B2 (en) * 2004-02-19 2008-06-03 Bristol-Myers Squibb Company Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
US20070270417A1 (en) * 2004-07-22 2007-11-22 Glaxo Group Limited Antibacterial Agents
ATE507832T1 (de) * 2004-09-03 2011-05-15 Athersys Inc Trizyklische heteroaryl-piperazine, pyrrolidine und azetidine als serotonin-rezeptor-modulatoren
CN101050194B (zh) * 2006-04-05 2013-08-21 上海恒瑞医药有限公司 双环辛烷类衍生物、其制备方法及其在医药上的用途

Also Published As

Publication number Publication date
EP2133077A4 (en) 2010-12-22
AU2007345133B2 (en) 2013-02-21
CN101914092B (zh) 2012-12-26
AU2007345133A1 (en) 2008-07-31
RU2009124304A (ru) 2011-02-27
CN101230058A (zh) 2008-07-30
CA2673164C (en) 2016-05-10
EP2133077B1 (en) 2014-08-13
US20100016314A1 (en) 2010-01-21
EP2133077A1 (en) 2009-12-16
KR101482159B1 (ko) 2015-01-13
CN101914092A (zh) 2010-12-15
US8178575B2 (en) 2012-05-15
JP2010516635A (ja) 2010-05-20
AU2007345133B8 (en) 2013-05-02
KR20090108093A (ko) 2009-10-14
RU2447063C2 (ru) 2012-04-10
BRPI0719650A2 (pt) 2013-12-10
WO2008089636A1 (en) 2008-07-31
CA2673164A1 (en) 2008-07-31
HK1117164A1 (en) 2009-01-09
JP5424256B2 (ja) 2014-02-26

Similar Documents

Publication Publication Date Title
MX2009007765A (es) Derivados de azabiciclo-octano, el metodo de obtenerlos y sus usos como inhibidores de la dipeptidil-peptidasa iv.
TW200614988A (en) Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation
WO2009117676A3 (en) Novel piperidine derivatives as inhibitors of stearoyl-coa desaturase
GEP20094679B (en) Dipeptidyl peptidase inhibitors
GEP20125652B (en) cMET INHIBITORS
MY150787A (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of prevention of diabetes
MX2010009416A (es) Compuestos heterociclicos como inhibidores de cxcr2.
MX2009008264A (es) Compuestos espiro heterociclicos.
WO2007035629A3 (en) Process for the preparation of pyrimidinedione derivatives
ATE522518T1 (de) Indazol- und isoindolderivate als glucokinaseaktivierende stoffe
MY150102A (en) Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
MX2012004210A (es) Derivados de pirazol como moduladores del canal de calcio activado por liberacion de calcio.
WO2008040995A8 (en) Indazoles for use as dpp-iv inhibitors
TW200616623A (en) Organic compounds
MY152749A (en) Pyrazole and fused pyrazole glucokinase activators
TNSN08367A1 (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
MX2011001679A (es) Derivados de flavina.
TW200611898A (en) Organic compounds
IN2012DN00721A (https=)
UA94417C2 (ru) Замещенные 7-азаиндазолы, композиция, которая их содержит, и применение
MX2010001754A (es) Derivados de azepina como inhibidores de gamma secretasa.
TW200745067A (en) Novel compounds
MX2010007927A (es) Derivados de 4-(pirrolo[2,3-c]piridin-3-il)pirimidin-2-ilamina.
MX2012006805A (es) Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa.
EA011572B9 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов

Legal Events

Date Code Title Description
FG Grant or registration